ଇକାଟିବାଣ୍ଟ

ଇକାଟିବାଣ୍ଟ
Clinical data
Trade names	Firazyr
Synonyms	Hoe 140, JE 049
AHFS/Drugs.com	monograph
data	EU EMA: yes; US DailyMed: Icatibant;
Pregnancy; category	AU: C ; ;
Routes of; administration	Subcutaneous
Legal status
Legal status	AU: S4 (Prescription only) ; US: ℞-only ; EU: Rx-only ; ℞ (Prescription only);
Identifiers
	IUPAC name (2S)-2-[[(3aS,7aS)-1-[2-[(2S)-2-[[(2S)-; 2-[[2-[[(4R)-1-[1-[2-[[(2R)-2-amino-5-(diaminomethylideneamino); pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-; 2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-; 3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]; 3,4-dihydro-1H-isoquinoline-3-carbonyl]; 2,3,3a,4,5,6,7,7a-octahydroindole-2-carbonyl]amino]-; 5-(diaminomethylideneamino)pentanoic acid;
Chemical and physical data
Formula	C59H89N19O13S
Molar mass	୧,୩୦୪.୫୪ g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CC[C@H]2[C@@H](C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)[C@H](CO)NC(=O)[C@H](CC5=CC=CS5)NC(=O)CNC(=O)C6C[C@H](CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)N)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O;
	InChI InChI=1S/C59H89N19O13S/c60-37(14-5-19-67-57(61)62)48(82)72-38(15-6-20-68-58(63)64)52(86)75-22-8-18-43(75)54(88)77-30-35(80)26-44(77)50(84)70-28-47(81)71-40(27-36-13-9-23-92-36)49(83)74-41(31-79)53(87)76-29-34-12-2-1-10-32(34)24-46(76)55(89)78-42-17-4-3-11-33(42)25-45(78)51(85)73-39(56(90)91)16-7-21-69-59(65)66/h1-2,9-10,12-13,23,33,35,37-46,79-80H,3-8,11,14-22,24-31,60H2,(H,70,84)(H,71,81)(H,72,82)(H,73,85)(H,74,83)(H,90,91)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69)/t33-,35+,37+,38-,39-,40-,41-,42-,43-,44-,45?,46+/m0/s1 ; Key:QURWXBZNHXJZBE-OVZQYVDUSA-N ;
(verify)

ଇକାଟିବାଣ୍ଟ, ଫିରାଜିର ବ୍ରାଣ୍ଡ ନାମରେ ବିକ୍ରି ହେଉଛି, ଏକ ଔଷଧ ଯାହା ଯଥେଷ୍ଟ ପରିମାଣର ସି୧-ଇଷ୍ଟରେଜ ଇନହିବିଟର ନଥିବା ଲୋକଙ୍କ ମଧ୍ୟରେ ବଂଶଗତ ଆଞ୍ଜିଓଇଡିମା (ଏଚଏଇ/HAE) ଆକ୍ରମଣର ଚିକିତ୍ସା ପାଇଁ ବ୍ୟବହୃତ ହୁଏ ।^[୩] ^[୨] ଏସିଇ ଇନହିବିଟର କାରଣରୁ ହେଉଥିବା ଆଞ୍ଜିଓଇଡିମା ପାଇଁ ଏହା ପ୍ରଭାବଶାଳୀ ହେବା ଦେଖାଯାଏ ନାହିଁ ।^[୪] ^[୫] ଚର୍ମ ତଳେ ଇଞ୍ଜେକସନ ଆକାରରେ ଏହା ଦିଆଯାଏ ।^[୨]

ସାଧାରଣ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ ଇଞ୍ଜେକ୍ସନ ସ୍ଥାନରେ ଲାଲ ରଙ୍ଗ, ଗଲୁ ଏବଂ ଯନ୍ତ୍ରଣା ହୋଇପାରେ ।^[୨] ଅନ୍ୟ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ ଜ୍ୱର, ମୁଣ୍ଡବିନ୍ଧା ଏବଂ ବାନ୍ତି ହୋଇପାରେ ।^[୬] ଗର୍ଭାବସ୍ଥାରେ ଏହି ଔଷଧ ଜନିତ ସୁରକ୍ଷା ଅସ୍ପଷ୍ଟ ଅଟେ | ^[୭] ଏହା ଏକ ବ୍ରାଡିକାଇନିନ ବି 2 ରିସେପ୍ଟର ଇନହିବିଟର ।^[୩]

୨୦୦୮ ମସିହାରେ ୟୁରୋପରେ ଏବଂ ୨୦୧୧ରେ ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଚିକିତ୍ସା କ୍ଷେତ୍ରରେ ବ୍ୟବହାର ପାଇଁ ଇକାଟିବାଣ୍ଟ ଅନୁମୋଦିତ ହୋଇଥିଲା ।^[୨] ^[୮] ଯୁକ୍ତରାଜ୍ୟରେ ଏହାର ପ୍ରତି ମାତ୍ରା ପାଇଁ ପ୍ରାୟ ୧,୪୦୦ ପାଉଣ୍ଡ ଖର୍ଚ୍ଚ ହୁଏ ।^[୬] ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଏହି ରାଶିର ମୂଲ୍ୟ ପ୍ରାୟ ୩,୬୦୦ ଡଲାର ଅଟେ ।^[୯]

ଆଧାର

↑ "Icatibant: HOE 140, JE 049, JE049". Drugs in R&D. 5 (6): 343–8. 2004. doi:10.2165/00126839-200405060-00006. PMID 15563238.
↑ ^୨.୦ ^୨.୧ ^୨.୨ ^୨.୩ ^୨.୪ "Firazyr EPAR". European Medicines Agency (EMA). Archived from the original on 12 April 2020. Retrieved 17 April 2020.
↑ ^୩.୦ ^୩.୧ ^୩.୨ "Firazyr- icatibant acetate injection, solution". DailyMed. 16 December 2019. Archived from the original on 3 August 2020. Retrieved 17 April 2020.
↑ Jeon, J; Lee, YJ; Lee, SY (October 2019). "Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials". Journal of clinical pharmacy and therapeutics. 44 (5): 685–692. doi:10.1111/jcpt.12997. PMID 31290163.
↑ Sinert R, Levy P, Bernstein JA, Body R, Sivilotti ML, Moellman J, Schranz J, Baptista J, Kimura A, Nothaft W (September–October 2017). "Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema". The Journal of Allergy and Clinical Immunology. In Practice. 5 (5): 1402–1409.e3. doi:10.1016/j.jaip.2017.03.003. PMID 28552382. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
↑ ^୬.୦ ^୬.୧ BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 306. ISBN 978-0857114105.BNF 81: March-September
↑ "Icatibant (Firazyr) Use During Pregnancy". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 4 December 2020. Retrieved 25 November 2021.
↑ "Icatibant Monograph for Professionals". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 23 January 2021. Retrieved 25 November 2021.
↑ "Icatibant Prices, Coupons & Patient Assistance Programs". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 24 January 2021. Retrieved 25 November 2021.

[1] "Icatibant: HOE 140, JE 049, JE049". Drugs in R&D. 5 (6): 343–8. 2004. doi:10.2165/00126839-200405060-00006. PMID 15563238.

[EPAR2021-2] ୨.୦ ^୨.୧ ^୨.୨ ^୨.୩ ^୨.୪ "Firazyr EPAR". European Medicines Agency (EMA). Archived from the original on 12 April 2020. Retrieved 17 April 2020.

[PI2021-3] ୩.୦ ^୩.୧ ^୩.୨ "Firazyr- icatibant acetate injection, solution". DailyMed. 16 December 2019. Archived from the original on 3 August 2020. Retrieved 17 April 2020.

[4] Jeon, J; Lee, YJ; Lee, SY (October 2019). "Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials". Journal of clinical pharmacy and therapeutics. 44 (5): 685–692. doi:10.1111/jcpt.12997. PMID 31290163.

[5] Sinert R, Levy P, Bernstein JA, Body R, Sivilotti ML, Moellman J, Schranz J, Baptista J, Kimura A, Nothaft W (September–October 2017). "Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema". The Journal of Allergy and Clinical Immunology. In Practice. 5 (5): 1402–1409.e3. doi:10.1016/j.jaip.2017.03.003. PMID 28552382. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)

[BNF81-6] ୬.୦ ^୬.୧ BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 306. ISBN 978-0857114105.BNF 81: March-September

[7] "Icatibant (Firazyr) Use During Pregnancy". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 4 December 2020. Retrieved 25 November 2021.

[AHFS2021-8] "Icatibant Monograph for Professionals". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 23 January 2021. Retrieved 25 November 2021.

[9] "Icatibant Prices, Coupons & Patient Assistance Programs". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 24 January 2021. Retrieved 25 November 2021.

[୩]

[୨]

[୪]

[୫]

[୧]

[୬]

[୭]

[୮]

[୯]